Physician profile
David Michael Lovit
NPI 1346260445
$3,956.74
in general payments reported to CMS, 2019-2025
9 companies · $1,600 in 2025
The $1,600 reported for 2025 was more than what 97% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.82 · 2020: $73.65 · 2021: $454 · 2022: $33.08 · 2023: $488 · 2024: $1,236 · 2025: $1,600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $1,226 · Food and Beverage: $992 · Debt Forgiveness: $628 · Education: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $1,226.37 |
| Food and Beverage | $991.75 |
| Debt Forgiveness | $627.50 |
| Education | $478.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $1,366.45 | 2021-2025 | Opalescence |
| Straumann USA LLC | $1,237.04 | 2019-2025 | |
| Zimvie INC. | $1,056.53 | 2024-2025 | |
| Centrix INC | $148.62 | 2021 | |
| Envista Holdings Corporation | $47.31 | 2025 | Zirconia Abutment Preparation Kit, Optibond Solo Plus |
| Dentsply Sirona INC | $41.79 | 2024 | Implant Dentistry, Suresmile |
| Southern Implants North America INC | $22.60 | 2021 | |
| Orapharma, A Division of Bausch Health US, LLC | $18.46 | 2021 | |
| Kulzer, LLC | $17.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lovit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.